This information sheet urges people with the hepatitis C virus (HCV) who want to try alternative treatments to follow these guidelines. Patients are encouraged to: check with their doctor first; see an expert; and beware of false promises. Talk to people who have been to an alternative treatment expert in the past to be sure the expert has a good reputation, licenses, and certificates. False promises, such as certain herbal remedies, supplements, certain vitamins, or "natural" medicines, can be very dangerous for people with HCV because they may hurt the liver.

This information sheet explains how to get treatment through a clinical trial for the hepatitis C virus. It explains how clinical trials work and what the different types of clinical trials are. It discusses informed consent, cost, how to find clinical trials, and the benefits and risks of participating in a clinical trial.

This information sheet discusses the difference between the hepatitis C virus (HCV) in women and in men. It states that women are more likely to clear the disease themselves, without treatment. The sheet also discusses how HCV is a silent disease, how it affects women, breastfeeding, and supplements.

This information sheet discusses the difference between advocates and activists and discusses the ways both are needed in the hepatitis C virus (HCV) community to bring more awareness to testing, prevention, and treatment.

This information sheet provides a brief history of hepatitis C and the major breakthroughs made in treating the hepatitis C virus (HCV) since it was identified.

This information sheet provides an overview of states’ policies on allowing minors to consent to health care, including care related to sexual activity and testing and treatment for STDs and HIV. It provides a table showing which states allow such consent and which states allow physicians to inform parents their children are requesting STD services.

This report provides graphs that demonstrate the continuum of HIV care among persons with HIV in Alabama in 2013. Categories include the estimated number of people with HIV, those diagnosed, those linked to care, those retained in care, and those with a suppressed viral load in both the state and in each public health zone.

This report is essentially a blueprint on how the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention will achieve its goals to eradicate the diseases they focus on. The report discusses goals, which align with the National HIV/AIDS Strategy, to reduce incidence, health disparities, morbidity, and mortality. The 8-page Executive Summary is available at: http://www.cdc.gov/nchhstp/docs/NCHHSTP-Strat-Plan-2020-Exec-Summary-508.pdf.

This poster illustrates the 12 populations being left behind worldwide in the fight against HIV/AIDS, including: people living with HIV but don't know it, young women, prisoners, migrants, injecting drug users, sex workers, men who have sex with men, transgendered persons, pregnant women, children, the homeless, people with disabilities, and people over 50 years of age.

This report reflects the findings of qualitative research completed to explore knowledge, benefits, barriers, and other factors that influence HIV treatment and focusedg on one of the key recommendations that resulted from a previous round of research: improving treatment literacy (including treatment as prevention or TasP). This research was comprised of two focus groups and two community forums, which took place in Washington D.C.